BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 36935283)

  • 21. Erythrocytapheresis as a novel treatment option for adult patients with pyruvate kinase deficiency.
    Jensen RFG; Dziegiel MH; Rieneck K; Birgens H; Glenthøj A
    Haematologica; 2020 Jul; 105(7):e373-e375. PubMed ID: 32273473
    [No Abstract]   [Full Text] [Related]  

  • 22. Mitapivat in adult patients with pyruvate kinase deficiency receiving regular transfusions (ACTIVATE-T): a multicentre, open-label, single-arm, phase 3 trial.
    Glenthøj A; van Beers EJ; Al-Samkari H; Viprakasit V; Kuo KHM; Galactéros F; Chonat S; Porter J; Zagadailov E; Xu R; Oluyadi A; Hawkins P; Gheuens S; Beynon V; Barcellini W;
    Lancet Haematol; 2022 Oct; 9(10):e724-e732. PubMed ID: 35988546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Residual pyruvate kinase activity in PKLR-deficient erythroid precursors of a patient suffering from severe haemolytic anaemia.
    Klei TRL; Kheradmand Kia S; Veldthuis M; Beuger BM; Geissler J; Dehbozorgian J; Karimi M; van Bruggen R; van Zwieten R
    Eur J Haematol; 2017 Jun; 98(6):584-589. PubMed ID: 28295642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of a High Number of Healthy Erythroid Cells from Gene-Edited Pyruvate Kinase Deficiency Patient-Specific Induced Pluripotent Stem Cells.
    Garate Z; Quintana-Bustamante O; Crane AM; Olivier E; Poirot L; Galetto R; Kosinski P; Hill C; Kung C; Agirre X; Orman I; Cerrato L; Alberquilla O; Rodriguez-Fornes F; Fusaki N; Garcia-Sanchez F; Maia TM; Ribeiro ML; Sevilla J; Prosper F; Jin S; Mountford J; Guenechea G; Gouble A; Bueren JA; Davis BR; Segovia JC
    Stem Cell Reports; 2015 Dec; 5(6):1053-1066. PubMed ID: 26549847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erythrocyte pyruvate kinase deficiency: 2015 status report.
    Grace RF; Zanella A; Neufeld EJ; Morton DH; Eber S; Yaish H; Glader B
    Am J Hematol; 2015 Sep; 90(9):825-30. PubMed ID: 26087744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pyruvate kinase deficiency and severe congenital hemolytic anemia in a double heterozygous patient with paternal transmission of an early germ-line de novo mutation.
    Mañú-Pereira Mdel M; Gonzalez-Roca E; van Solinge WW; Llaudet-Planas E; Sevilla J; Montllor L; Mensa-Vilaro A; Ploos van Amstel HK; van Wijk R; Vives-Corrons J
    Am J Hematol; 2015 Dec; 90(12):E217-9. PubMed ID: 26315463
    [No Abstract]   [Full Text] [Related]  

  • 27. Safe and Efficient Gene Therapy for Pyruvate Kinase Deficiency.
    Garcia-Gomez M; Calabria A; Garcia-Bravo M; Benedicenti F; Kosinski P; López-Manzaneda S; Hill C; Del Mar Mañu-Pereira M; Martín MA; Orman I; Vives-Corrons JL; Kung C; Schambach A; Jin S; Bueren JA; Montini E; Navarro S; Segovia JC
    Mol Ther; 2016 Aug; 24(7):1187-98. PubMed ID: 27138040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and in silico characterization of a novel PKLR genotype in a Turkish newborn.
    Canu G; De Paolis E; Righino B; Mazzuccato G; De Paolis G; Capoluongo E; De Rosa MC; Urbani A; Gunes AM; Minucci A
    Mol Biol Rep; 2020 Oct; 47(10):8311-8315. PubMed ID: 32974842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How we manage patients with pyruvate kinase deficiency.
    Grace RF; Mark Layton D; Barcellini W
    Br J Haematol; 2019 Mar; 184(5):721-734. PubMed ID: 30681718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two Novel Missense Mutations and a 5bp Deletion in the Erythroid-Specific Promoter of the PKLR Gene in Two Unrelated Patients With Pyruvate Kinase Deficient Transfusion-Dependent Chronic Nonspherocytic Hemolytic Anemia.
    Kager L; Minkov M; Zeitlhofer P; Fahrner B; Ratzinger F; Boztug K; Dossenbach-Glaninger A; Haas OA
    Pediatr Blood Cancer; 2016 May; 63(5):914-6. PubMed ID: 26728349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Iron status in patients with pyruvate kinase deficiency: neonatal hyperferritinaemia associated with a novel frameshift deletion in the PKLR gene (p.Arg518fs), and low hepcidin to ferritin ratios.
    Mojzikova R; Koralkova P; Holub D; Zidova Z; Pospisilova D; Cermak J; Striezencova Laluhova Z; Indrak K; Sukova M; Partschova M; Kucerova J; Horvathova M; Divoky V
    Br J Haematol; 2014 May; 165(4):556-63. PubMed ID: 24533562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemolytic anemia associated with a novel heterozygote mutation 1183A in the PK-LR gene (PK- Jordan).
    Karadsheh NS; Gelbart T; Naffa RG
    Int J Lab Hematol; 2014 Aug; 36(4):e66-8. PubMed ID: 24330591
    [No Abstract]   [Full Text] [Related]  

  • 33. Pyruvate kinase deficiency in children.
    Chonat S; Eber SW; Holzhauer S; Kollmar N; Morton DH; Glader B; Neufeld EJ; Yaish HM; Rothman JA; Sharma M; Ravindranath Y; Wang H; Breakey VR; Sheth S; Bradeen HA; Al-Sayegh H; London WB; Grace RF
    Pediatr Blood Cancer; 2021 Sep; 68(9):e29148. PubMed ID: 34125488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of pyruvate kinase as therapeutic option for rare hemolytic anemias: Shedding new light on an old enzyme.
    van Dijk MJ; de Wilde JRA; Bartels M; Kuo KHM; Glenthøj A; Rab MAE; van Beers EJ; van Wijk R
    Blood Rev; 2023 Sep; 61():101103. PubMed ID: 37353463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Chronic non-spherocytic hemolytic anemia caused by pyruvate kinase deficiency in a Costa Rican family carrying hemoglobin C disease].
    Chaves M; Vives-Corrons JL; Sáenz GF; Pujades MA; Briceño J; Colomer D
    Sangre (Barc); 1990 Apr; 35(2):128-33. PubMed ID: 2363093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A pyruvate kinase deficiency child with novel PK-LR gene mutations was successfully cured by matched unrelated donor peripheral blood stem cell transplantation.
    Zhan LP; Que LP; Wu ZZ; Liu DD; Wang KM; Xu HG; Fang JP; Huang K
    Pediatr Transplant; 2021 Nov; 25(7):e14078. PubMed ID: 34255916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Partial pyruvate kinase deficiency aggravates the phenotypic expression of band 3 deficiency in a family with hereditary spherocytosis.
    van Zwieten R; van Oirschot BA; Veldthuis M; Dobbe JG; Streekstra GJ; van Solinge WW; Schutgens RE; van Wijk R
    Am J Hematol; 2015 Mar; 90(3):E35-9. PubMed ID: 25388786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alu element insertion in PKLR gene as a novel cause of pyruvate kinase deficiency in Middle Eastern patients.
    Lesmana H; Dyer L; Li X; Denton J; Griffiths J; Chonat S; Seu KG; Heeney MM; Zhang K; Hopkin RJ; Kalfa TA
    Hum Mutat; 2018 Mar; 39(3):389-393. PubMed ID: 29288557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Six novel variants in the PKLR gene associated with pyruvate kinase deficiency in Argentinian patients.
    Milanesio B; Pepe C; Defelipe LA; Eandi Eberle S; Avalos Gomez V; Chaves A; Albero A; Aguirre F; Fernandez D; Aizpurua L; Paula Dieuzeide M; Turjanski A; Bianchi P; Fermo E; Feliu-Torres A
    Clin Biochem; 2021 May; 91():26-30. PubMed ID: 33631127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improving the laboratory diagnosis of pyruvate kinase deficiency.
    Laas C; Lambert C; Senior McKenzie T; Sheldon E; Davidson P; Rees D; Clark B
    Br J Haematol; 2021 Jun; 193(5):994-1000. PubMed ID: 33937978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.